|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 181.20 USD | +1.30% |
|
-0.51% | +50.56% |
| Jun. 27 | Deutsche Bank Adjusts PT on Philip Morris International to $195 From $184, Maintains Buy Rating | MT |
| Jun. 26 | Philip Morris International Inc.(NYSE:PM) added to Russell Top 50 Index | CI |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Cigarettes | ||||||||||
Europe | - | - | - | 13.6B | 15.36B | |||||
CAPEX | - | - | - | -778M | -783M | |||||
D&A | - | - | - | 333M | 492M | |||||
Operating Income | - | - | - | 6.01B | 6.94B | |||||
SSEA, CIS & MEA | - | - | - | 10.63B | 11.26B | |||||
CAPEX | - | - | - | -287M | -306M | |||||
D&A | - | - | - | 309M | 304M | |||||
Operating Income | - | - | - | 3.05B | 3.43B | |||||
EA, AU & PMI GTR | - | - | - | 6.2B | 6.39B | |||||
CAPEX | - | - | - | -38M | -22M | |||||
D&A | - | - | - | 148M | 173M | |||||
Operating Income | - | - | - | 2.48B | 2.88B | |||||
Americas | - | - | - | 1.94B | 4.53B | |||||
CAPEX | - | - | - | -57M | -280M | |||||
D&A | - | - | - | 77M | 748M | |||||
Operating Income | - | - | - | 62M | 548M | |||||
Swedish Match | - | - | - | 2.5B | - | |||||
CAPEX | - | - | - | -127M | - | |||||
D&A | - | - | - | 447M | - | |||||
Operating Income | - | - | - | 824M | - | |||||
Manufacture and Sale of Cigarettes and Other Nicotine-Containing Products | 28.69B | 31.4B | 31.76B | - | - | |||||
Total Assets | 44.82B | 41.29B | 61.68B | - | - | |||||
Interest Expense | -728M | -737M | -768M | - | - | |||||
Income Tax Expense | 2.38B | 2.67B | 2.24B | - | - | |||||
CAPEX | -602M | -748M | -1.08B | - | - | |||||
EBT | 10.95B | 12.23B | 11.63B | - | - | |||||
Gross Profit | 19.12B | 21.38B | 20.36B | - | - | |||||
D&A | 981M | 998M | 1.19B | - | - | |||||
Operating Income | 11.67B | 12.98B | 12.25B | - | - | |||||
Net Income | 8.06B | 9.11B | 9.05B | - | - | |||||
Pharmaceutical Products | ||||||||||
Wellness and Healthcare | - | - | - | 306M | 333M | |||||
CAPEX | - | - | - | -34M | -53M | |||||
D&A | - | - | - | 84M | 70M | |||||
Operating Income | - | - | - | -870M | -391M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | - | - | - | - | - | |||||
Swedish Match | - | - | 316M | - | - | |||||
D&A | - | - | 34M | - | - | |||||
Operating Income | - | - | -22M | - | - | |||||
Unallocated | - | - | 271M | - | - | |||||
Total Assets | - | 210M | 1.46B | - | - | |||||
D&A | - | - | 197M | - | - | |||||
Operating Income | - | - | -258M | - | - | |||||
East Asia & Australia (Excluding Japan) | 1.33B | 1.35B | 1.23B | - | - | |||||
Japan | 4.1B | 4.6B | 3.9B | - | - | |||||
South & Southeast Asia (Excluding Indonesia) | - | - | - | - | - | |||||
Total Assets | 648M | 486M | - | - | - | |||||
South & Southeast Asia | 4.4B | 4.4B | 4.4B | - | - | |||||
Total Assets | - | - | 1.36B | - | - | |||||
D&A | 137M | 143M | 151M | - | - | |||||
CAPEX | -115M | -52M | -179M | - | - | |||||
Operating Income | 1.71B | 1.51B | 1.46B | - | - | |||||
Total Assets | 807M | 740M | 674M | - | - | |||||
D&A | 188M | 154M | 151M | - | - | |||||
CAPEX | -13M | -36M | -24M | - | - | |||||
Operating Income | 2.4B | 2.56B | 1.92B | - | - | |||||
Middle East & Africa | 3.09B | 3.29B | 3.9B | - | - | |||||
Total Assets | 375M | 289M | 244M | - | - | |||||
D&A | 75M | 89M | 96M | - | - | |||||
CAPEX | -22M | -37M | -39M | - | - | |||||
Operating Income | 1.03B | 1.15B | 1.76B | - | - | |||||
Eastern Europe | 3.38B | 3.54B | 3.72B | - | - | |||||
Total Assets | 668M | 635M | 541M | - | - | |||||
D&A | 173M | 131M | 137M | - | - | |||||
CAPEX | -88M | -71M | -52M | - | - | |||||
Operating Income | 871M | 1.21B | 1.17B | - | - | |||||
Indonesia | - | - | - | - | - | |||||
Total Assets | 700M | 900M | - | - | - | |||||
Total Assets | 1.1B | 900M | - | - | - | |||||
Wellness and Healthcare | - | 101M | - | - | - | |||||
Total Assets | 1B | 292M | - | - | - | |||||
D&A | 11M | 16M | - | - | - | |||||
CAPEX | -2M | -28M | - | - | - | |||||
Operating Income | - | -52M | - | - | - | |||||
Total Assets | 2.1B | 2.3B | - | - | - | |||||
Total Assets | 1.3B | 1.3B | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Cigarettes | ||||||||||
Americas | 1.7B | 1.84B | 1.9B | - | - | |||||
Total Assets | 433M | 661M | 1.28B | - | - | |||||
D&A | 58M | 62M | 74M | - | - | |||||
CAPEX | -36M | -54M | -101M | - | - | |||||
Operating Income | 564M | 487M | 436M | - | - | |||||
European Union | 10.7B | 12.28B | 12.12B | - | - | |||||
Total Assets | - | - | 5.08B | - | - | |||||
D&A | 266M | 307M | 349M | - | - | |||||
CAPEX | -326M | -470M | -682M | - | - | |||||
Operating Income | 5.1B | 6.12B | 5.79B | - | - | |||||
Eastern Europe, Middle East & Africa | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Asia | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
- Stock Market
- Equities
- PM Stock
- Financials Philip Morris International, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
